Lääkealan turvallisuus- ja kehittämiskeskus Fimea - Selaus nimekkeen mukaan
Viitteet 697-716 / 5177
-
Children’s health and parental socioeconomic factors: a population-based survey in Finland
BMC Public Health (2011)Background: Socioeconomic inequalities in health are a global problem, not only among the adult population but also among children. However, studies concerning young children especially are rare. The aim of this study was ... -
Choice of oral antidiabetic drug
(Lääkelaitos, 1999) -
Choices to be made in the regulation of medical devices
(Lääkelaitos, 2008) -
Choices to be made in the regulation of medical devices
Tabu : 2 (Lääkelaitos, 2008) -
Ciklosporin : Atopica vet 10 mg, 25 mg, 50 mg och 100 mg kapslar för hund, Novartis Healthcare A/S, Danmark /
Tabu : 4 (Lääkelaitos, 2006) -
Cisaprid och ventrikulära arytmier
(Lääkelaitos, 2000) -
CKD Prevalence Varies across the European General Population
Journal of the American Society of Nephrology (American Society of Nephrology, 23.12.2015) -
Classification issues /
(Lääkelaitos, 2003) -
Classification issues /
Tabu : 3 (Lääkelaitos, 2003) -
Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union : How Are the Product Pipeline and Regulatory Framework Evolving?
Human Gene Therapy Clinical Development : 3 (Mary Ann Liebert, 01.09.2017)The research and development of advanced therapy medicinal products (ATMPs) has been active in Europe and worldwide during recent years. Yet, the number of licensed products remains low. The main expected legal change in ... -
Clinical drug trials notified to the National Agency for Medicines in 2003
(Lääkelaitos, 2004) -
Clinical drug trials notified to the National Agency for Medicines in 2003
Tabu : 5 (Lääkelaitos, 2004) -
Clinical trials in Finland 2007
(Lääkelaitos, 2008) -
Clinical trials in Finland 2007
Tabu : 3 (Lääkelaitos, 2008) -
Cntraindications for magnetic resonance imaging (MRI) and risks involved
(Lääkelaitos, 2008) -
Cntraindications for magnetic resonance imaging (MRI) and risks involved
Tabu : 5 (Lääkelaitos, 2008) -
Collaboration boosts quality control in Europe
(Lääkelaitos, 2002) -
Comment ; translation: Mervi Moisander
(Lääkelaitos, 2005) -
Comment ; translation: Mervi Moisander
Tabu : 4 (Lääkelaitos, 2005)